Session 299

The Pharma Industry’s New Contract with Society

Track P

Date: Tuesday, October 9, 2012


Time: 09:30 – 10:30

Showcase Panel

Room: Meeting Hall IV (a)

Session Chair:

  • Bala Chakravarthy, IMD

    photo of Bala Chakravarthy

    Bala Chakravarthy is Professor of Strategy and International Management and holds the Shell Chair in Sustainable Business Growth at IMD, Switzerland. Bala Chakravarthy’s research and teaching interests cover three related areas: strategy processes for sustainable business growth, corporate renewal, and leadership dilemmas. He has published four books, several case studies and numerous articles on these topics in top journals. He was a member of the Board of Directors of the Strategic Management Society (SMS) from 1999-2004. He is also an inaugural Fellow of the SMS.


The pharma industry has witnessed dramatic changes in the past decade. There is growing pressure to offer the latest drugs (still under patent) in emerging markets at prices that are closer to that of generic drugs. There is also pressure to tackle “diseases of the poor,” with uncertain economic payouts. Issues of social performance have moved away from the narrow confines of CSR departments to mainstream business units. New business models are being experimented with to resolve the inevitable dilemmas when striving for both financial and social performance. In this panel we bring the cutting edge experiences of two world leading pharma companies: Novartis and GlaxoSmithKline, and discus the emerging new contract between the pharma industry and society; and its consequences for firm strategy and general management behaviors.

All Sessions in Track P...

Sun: 13:45 – 14:45
Session 67: Pioneering the Way Towards the East: Early Entry and Transition Challenges
Sun: 15:15 – 16:30
Session 68: Business Schools in Transition: Models of Management Education and Research
Mon: 11:15 – 12:15
Session 69: SMS Lifetime Achievement Award Honoring Carlos Ghosn
Mon: 15:00 – 16:00
Session 260: Transitioning Towards the Sustainable Enterprise
Session 261: Opening Strategy: Creating More Transparent and Inclusive Strategy Processes at CERN , Intel and Atlassian
Tue: 09:30 – 10:30
Session 73: Driving Transition Strategies: Enhancing Entrepreneurial Spirit in Large Corporations
Session 74: Eurozone in Crisis: The Administrative Basis of Macroeconomic Meltdowns
Session 75: Editors’ Perspectives on Strategy in Transition
Session 299: The Pharma Industry’s New Contract with Society

Strategic Management Society